Carregant...

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease characterised by fibrosis of the lung parenchyma and loss of lung function. Although the pathogenic pathways involved in IPF have not been fully elucidated, IPF is believed to be caused by repetitive alveolar epithelia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Respir J
Autors principals: Wollin, Lutz, Wex, Eva, Pautsch, Alexander, Schnapp, Gisela, Hostettler, Katrin E., Stowasser, Susanne, Kolb, Martin
Format: Artigo
Idioma:Inglês
Publicat: European Respiratory Society 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4416110/
https://ncbi.nlm.nih.gov/pubmed/25745043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00174914
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!